000 | 02022 a2200601 4500 | ||
---|---|---|---|
005 | 20250518100502.0 | ||
264 | 0 | _c20201111 | |
008 | 202011s 0 0 eng d | ||
022 | _a1468-330X | ||
024 | 7 |
_a10.1136/jnnp-2020-323124 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFargeot, Guillaume | |
245 | 0 | 0 |
_aBrentuximab vedotin treatment associated with acute and chronic inflammatory demyelinating polyradiculoneuropathies. _h[electronic resource] |
260 |
_bJournal of neurology, neurosurgery, and psychiatry _c07 2020 |
||
300 |
_a786-788 p. _bdigital |
||
500 | _aPublication Type: Letter | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
650 | 0 | 4 |
_aBrentuximab Vedotin _xadverse effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGuillain-Barre Syndrome _xchemically induced |
650 | 0 | 4 |
_aHodgkin Disease _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLymphoma, Non-Hodgkin _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPolyradiculoneuropathy, Chronic Inflammatory Demyelinating _xchemically induced |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aDupel-Pottier, Corinne | |
700 | 1 | _aStephant, Maeva | |
700 | 1 | _aLazarovici, Julien | |
700 | 1 | _aThomas, Laure | |
700 | 1 | _aMouthon-Reignier, Capucine | |
700 | 1 | _aRiad, Benramdane | |
700 | 1 | _aCarde, Patrice | |
700 | 1 | _aBerzero, Giulia | |
700 | 1 | _aTafani, Camille | |
700 | 1 | _aNicolas, Weiss | |
700 | 1 | _aViala, Karine | |
700 | 1 | _aMaisonobe, Thierry | |
700 | 1 | _aLenglet, Timothée | |
700 | 1 | _aWang, Adrien | |
700 | 1 | _aMagy, Laurent | |
700 | 1 | _aBihan, Kevin | |
700 | 1 | _aGaspar, Nathalie | |
700 | 1 | _aAdams, David | |
700 | 1 | _aEchaniz-Laguna, Andoni | |
700 | 1 | _aCauquil, Cecile | |
700 | 1 | _aPsimaras, Dimitri | |
773 | 0 |
_tJournal of neurology, neurosurgery, and psychiatry _gvol. 91 _gno. 7 _gp. 786-788 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1136/jnnp-2020-323124 _zAvailable from publisher's website |
999 |
_c30893793 _d30893793 |